These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 18568913
1. In situ intestinal absorption of cyclosporine A solid dispersion in rats. Liu C, Zhu S, Zhou Y, Wei Y, Pei Y. Drug Dev Ind Pharm; 2008 Jun; 34(6):627-31. PubMed ID: 18568913 [Abstract] [Full Text] [Related]
2. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Fricker G, Drewe J, Huwyler J, Gutmann H, Beglinger C. Br J Pharmacol; 1996 Aug; 118(7):1841-7. PubMed ID: 8842452 [Abstract] [Full Text] [Related]
3. Enhancement of dissolution of cyclosporine A using solid dispersions with polyoxyethylene (40) stearate. Liu C, Zhu SJ, Zhou Y, Wei YP, Pei YY. Pharmazie; 2006 Aug; 61(8):681-4. PubMed ID: 16964710 [Abstract] [Full Text] [Related]
4. Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension. Bravo González RC, Huwyler J, Walter I, Mountfield R, Bittner B. Int J Pharm; 2002 Oct 01; 245(1-2):143-51. PubMed ID: 12270251 [Abstract] [Full Text] [Related]
5. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Ugazio E, Cavalli R, Gasco MR. Int J Pharm; 2002 Jul 25; 241(2):341-4. PubMed ID: 12100861 [Abstract] [Full Text] [Related]
6. Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier. Zhang Y, Li X, Zhou Y, Fan Y, Wang X, Huang Y, Liu Y. Mol Pharm; 2010 Aug 02; 7(4):1169-82. PubMed ID: 20540526 [Abstract] [Full Text] [Related]
7. The absorption behavior of cyclosporin A lecithin vesicles in rat intestinal tissue. Chen Y, Ping Q, Guo J, Lv W, Gao J. Int J Pharm; 2003 Aug 11; 261(1-2):21-6. PubMed ID: 12878392 [Abstract] [Full Text] [Related]
8. Equivalence of cyclosporine blood level assays in patients receiving cyclosporine microemulsion or cyclosporine. The Sandoz Neoral Study Group N103. Pescovitz MD, Wong RL, Choc MG, Chang CT. Clin Transplant; 1997 Oct 11; 11(5 Pt 1):442-5. PubMed ID: 9361938 [Abstract] [Full Text] [Related]
9. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability. Varma MV, Panchagnula R. J Pharm Sci; 2005 Aug 11; 94(8):1694-704. PubMed ID: 15986467 [Abstract] [Full Text] [Related]
10. [Preparation of cyclosporine A loaded mPEG-PLGA copolymer micelles and study its pharmacokinetics in rats]. Yao DG, Sun KX, Mu HJ, Zhou FM, Chen HH, Liu LJ, Liang N. Yao Xue Xue Bao; 2009 Dec 11; 44(12):1410-5. PubMed ID: 21351479 [Abstract] [Full Text] [Related]
20. Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine. Jin M, Shimada T, Shintani M, Yokogawa K, Nomura M, Miyamoto K. Drug Metab Pharmacokinet; 2005 Oct 11; 20(5):324-30. PubMed ID: 16272749 [Abstract] [Full Text] [Related] Page: [Next] [New Search]